ube2wa Antibody

What is the UBE2W protein and why is it important in research?

UBE2W (Ubiquitin-Conjugating Enzyme E2W) is a specialized E2 enzyme within the ubiquitin proteasome system that accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins . Unlike many E2 enzymes, UBE2W specifically catalyzes monoubiquitination and is involved in protein degradation pathways . This unique function makes UBE2W an important target for research investigating protein quality control, degradation mechanisms, and associated pathologies. The amino acid sequence 1-151 constitutes the full-length protein that is typically targeted by commercially available antibodies .

What criteria should guide UBE2W antibody selection for experimental applications?

When selecting a UBE2W antibody, researchers should consider several critical parameters:

• Epitope specificity: Antibodies targeting different amino acid regions (e.g., AA 1-151, 71-151, or 90-170) may yield varying results depending on protein conformation and accessibility .

• Host species: Rabbit and mouse-derived antibodies are commonly available, with rabbit polyclonal being prevalent for UBE2W detection .

• Application compatibility: Verify validation for your specific application (Western blot, immunohistochemistry, immunofluorescence, ELISA) .

• Species cross-reactivity: Confirm reactivity with your experimental model (human, mouse, rat) .

• Conjugation: Consider whether a conjugated antibody (FITC, biotin, HRP) or unconjugated format best suits your experimental design .

How do polyclonal and monoclonal UBE2W antibodies differ in research applications?

Polyclonal antibodies recognize multiple epitopes, providing robust signal detection in applications like western blotting where protein denaturation may obscure some epitopes. Monoclonal antibodies offer superior specificity and consistency across experiments, making them valuable for quantitative analyses .

What are the validated applications for UBE2W antibodies and their optimal protocols?

Based on current research tools, UBE2W antibodies have been validated for several applications with specific optimization parameters:

• Western Blotting: The most commonly validated application, with recommended dilutions ranging from 1:500-1:3000, similar to optimization ranges for related ubiquitin-conjugating enzymes .

• Immunohistochemistry: Both paraffin-embedded (IHC-p) and frozen section (IHC-fro) protocols have been validated for specific antibodies targeting amino acids 71-151 and 105-133 .

• Immunofluorescence: Both cellular (IF-cc) and tissue (IF-p) protocols are supported by antibodies targeting amino acids 71-151 .

• ELISA: Multiple UBE2W antibodies have been validated for ELISA applications, particularly those targeting amino acids 1-151, 17-112, and 71-151 .

How should researchers optimize western blotting protocols for UBE2W detection?

For optimal western blotting results when detecting UBE2W:

• Protein extraction: Use buffers containing deubiquitinase inhibitors to preserve ubiquitination status.

• Sample preparation: Maintain samples at 4°C to prevent degradation of ubiquitinated proteins.

• Gel percentage: Use 12-15% gels for optimal resolution of UBE2W (~17-20 kDa).

• Transfer conditions: Semi-dry transfer at 15V for 30 minutes or wet transfer at 100V for 1 hour.

• Blocking: 5% non-fat milk in TBST for 1 hour at room temperature.

• Primary antibody: Start with 1:1000 dilution in 5% BSA/TBST, incubate overnight at 4°C .

• Secondary antibody: Use at 1:5000-1:10000 dilution for 1 hour at room temperature.

• Detection: ECL substrates are typically sufficient; for low expression, consider enhanced chemiluminescence reagents.

This protocol draws upon optimization techniques similar to those used for related ubiquitin-conjugating enzymes like UBE2C, which has a similar molecular weight (20 kDa) .

How can researchers validate UBE2W antibody specificity for critical experiments?

Comprehensive validation of UBE2W antibody specificity should include:

• Positive and negative controls: Include tissue/cell lines known to express or lack UBE2W.

• Knockdown/knockout validation: Compare antibody signal in UBE2W-depleted samples (siRNA, CRISPR) against wild-type.

• Peptide competition assay: Pre-incubate antibody with immunizing peptide to confirm specific binding.

• Multiple antibody comparison: Use antibodies targeting different epitopes (e.g., N-terminal vs. C-terminal).

• Cross-reactivity assessment: Test against closely related E2 enzymes (UBE2B, UBE2C) to ensure specificity .

• Recombinant protein controls: Include purified UBE2W protein as a positive control.

• Mass spectrometry validation: Confirm identity of detected bands by mass spectrometry analysis.

These validation steps are particularly important for UBE2W given its membership in the large family of ubiquitin-conjugating enzymes with structural similarities.

What considerations are important when using UBE2W antibodies for multiparametric analyses?

When incorporating UBE2W antibodies into multiparametric analyses:

• Panel design: Consider spectral overlap when using fluorophore-conjugated antibodies like FITC-conjugated UBE2W antibodies .

• Antibody optimization: Titrate antibodies individually before combining them, as background signal in multiparametric analyses can compound .

• Signal-to-noise ratio: For oligo-conjugated antibodies, perform careful titration to optimize signal while minimizing background .

• Cross-reactivity: Ensure secondary antibodies do not cross-react with other primary antibodies in your panel.

• Fixation compatibility: Verify that fixation protocols are compatible with all antibodies in your multiplex panel.

• Sequential detection: Consider sequential rather than simultaneous detection if cross-reactivity issues emerge.

Research on CITE-seq and other single-cell multimodal techniques highlights the importance of careful antibody titration to improve signal quality in complex experiments .

What are common challenges with UBE2W antibodies and their solutions?

How can researchers optimize storage and handling of UBE2W antibodies to maintain activity?

For maximum preservation of UBE2W antibody activity:

• Storage temperature: Store at -20°C or -80°C for long-term storage; 2-8°C for short-term use .

• Aliquoting: Create single-use aliquots to avoid freeze-thaw cycles.

• Buffer composition: Typical storage buffers include 0.1M Tris, 0.1M Glycine, 20% Glycerol (pH7) with 0.01% Thimerosal as preservative .

• Reconstitution: Follow manufacturer's guidelines for reconstitution of lyophilized antibodies.

• Handling: Maintain cold chain during experiments; avoid prolonged exposure to room temperature.

• Contamination prevention: Use sterile techniques when handling antibody solutions.

• Expiration: Monitor expiration dates and perform validation tests on older antibody lots.

How are UBE2W antibodies contributing to understanding ubiquitination in disease mechanisms?

UBE2W antibodies have become instrumental in elucidating the role of monoubiquitination in various disease processes. Similar to research with UBE2C, which has shown dramatic upregulation in various tumors , UBE2W studies are helping researchers understand the functional consequences of altered ubiquitination pathways in pathological states. The ability to specifically detect UBE2W using well-characterized antibodies has enabled researchers to:

• Map tissue-specific expression patterns of UBE2W in normal and diseased tissues

• Identify alterations in UBE2W localization during disease progression

• Correlate UBE2W expression with specific disease biomarkers

• Track changes in UBE2W-mediated monoubiquitination during cellular stress responses

These investigations parallel studies of other E2 enzymes like UBE2C, which has been identified as a potential therapeutic target due to its overexpression in solid tumors .

What role do UBE2W antibodies play in studying protein quality control mechanisms?

UBE2W antibodies are critical tools for investigating protein quality control mechanisms, particularly in the context of:

• Protein aggregation disorders: Detecting UBE2W involvement in tagging misfolded proteins for degradation.

• Stress response pathways: Monitoring changes in UBE2W expression and localization during cellular stress.

• Organelle-specific degradation: Tracking UBE2W participation in organelle-specific quality control mechanisms.

• Post-translational modification crosstalk: Investigating interactions between UBE2W-mediated monoubiquitination and other post-translational modifications.

Recent advances in antibody-based techniques, including the development of nanovial technology for capturing individual cells , offer promising approaches for studying UBE2W at single-cell resolution, potentially revealing cell-type specific functions of this enzyme in quality control pathways.